Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
337 hedge funds and large institutions have $4.57B invested in Syneos Health, Inc. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 135 increasing their positions, 117 reducing their positions, and 61 closing their positions.
11,207% more call options, than puts
Call options by funds: $1.58M | Put options by funds: $14K
15% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 117
7% less funds holding
Funds holding: 362 → 337 (-25)
34% less capital invested
Capital invested by funds: $6.97B → $4.57B (-$2.4B)
34% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 61
83% less funds holding in top 10
Funds holding in top 10: 6 → 1 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.5M |
| 2 |
Millennium Management
New York
|
+$36.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$32.2M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$30.6M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$78.5M |
| 2 |
BlackRock
New York
|
-$62.8M |
| 3 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$57.6M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$46.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$39.4M |
SYNH Hedge Fund Activity: Q3 2022 in Review
337 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q3 2022, worth a combined $4.57B — down 34% from $6.97B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of SYNH and 40 opened new positions — a net loss of 21 holders — while 117 trimmed existing stakes and 135 added.
The largest buyer was Fidelity Investments, adding an estimated $46.5M. The largest seller was Invesco, cutting an estimated $78.5M.
- 337 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q3 2022, down from 362 in Q2 2022.
- Funds reported $4.57B of Syneos Health, Inc. Class A Common Stock stock for Q3 2022, down 34% quarter-over-quarter.
- 40 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q3 2022 and 61 closed out, a net change of -21 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q3 2022 was Fidelity Investments, an estimated $46.5M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q3 2022 was Invesco, an estimated $78.5M sold.
Based on aggregated 13F filings for Q3 2022.